It is also stable in harsh conditions like stomach acid, a rare trait for peptide drugs
Second, as an observational study, causality cannot be established, and the findings remain susceptible to residual confounding from unmeasured factors, including confounding by indication, disease severity, prescribing preferences, and lifestyle factors such as diet, physical activity, or cognitive engagement
This surge is driven by blockbuster products like Novo Nordisks Wegovy (semaglutide) and Eli Lillys Mounjaro/Zepbound (tirzepatide), whose weight-loss sales doubled or more year-over-year ( [3] ) ( [4] )
Several medical conditions, including celiac disease, cystic fibrosis, and diabetes, can cause exocrine pancreatic insufficiency (EPI)
The amounts vary based on the dose you take and how long you use the medication